Jan 30, 2018 7:00 am EST Heat Biologics to Host Analyst and Investor Event February 28, 2018 to Present Results from its Phase 2 Lung Cancer Study
Dec 07, 2017 7:00 am EST Heat Biologics Receives FDA Guidance at Type C Meeting for HS-110 Clinical Trial in the Treatment of Non-small Cell Lung Cancer
Nov 11, 2017 1:00 pm EST Heat Biologics Presents Follow-up Data on its ComPACT™ T-cell Stimulating Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 06, 2017 8:00 am EST Heat Biologics to Present Data on its ComPACT Technology, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 30, 2017 8:00 am EDT Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives Second Tranche of its $15.2 Million CPRIT Grant Award
Oct 27, 2017 7:00 am EDT Heat Biologics Rights Offering Materials Available for Shareholders of Record